USP47 Activators

The chemical class USP47 Activators consists of compounds that can indirectly influence the activity of USP47 through their effects on the ubiquitin-proteasome system and related protein degradation pathways. These compounds do not directly activate USP47 but modulate the cellular environment in ways that can affect its function. Compounds like MG132, Bortezomib, Velcade, Epoxomicin, and Lactacystin are proteasome inhibitors. By inhibiting proteasomal activity, these compounds lead to an accumulation of ubiquitin-protein conjugates. This accumulation potentially impacts USP47, as its role in deubiquitinating proteins becomes more crucial when ubiquitinated proteins are abundant.

Other compounds, including Ubiquitin Aldehyde, PYR-41, NSC697923, IU1, ML323, P5091, and WP1130, influence various aspects of the ubiquitin-proteasome system. For example, PYR-41, a ubiquitin-activating enzyme inhibitor, and NSC697923, a UBE2N inhibitor, alter the ubiquitination levels in cells, which can impact the function of deubiquitinating enzymes like USP47. Similarly, inhibitors of specific USPs, such as IU1, ML323, P5091, and WP1130, modulate the deubiquitination process, potentially influencing USP47's activity in the cellular context.